A cadaveric donor is a person whose organs or tissues are recovered for transplantation after they have died. The term “cadaveric” simply means “from a deceased person,” and in transplant medicine it distinguishes this pathway from living donation, where a healthy person gives a kidney or a portion of their liver while still alive. Most solid organ transplants worldwide come from cadaveric donors, and the process that connects a person’s death to another person’s transplant involves a tightly coordinated chain of medical, legal, and logistical steps that can unfold over just hours.
Two Pathways to Deceased Donation
Not all cadaveric donors die in the same way, and the distinction matters for how organs are recovered. The two recognized categories are donation after brain death (DBD) and donation after circulatory death (DCD). In DBD, the donor has suffered irreversible loss of all brain function, including the brainstem, while their heart continues to beat with the support of a ventilator. In DCD, the donor’s heart stops and circulation ceases, either after life-sustaining treatment is withdrawn or after an unexpected cardiac arrest that cannot be reversed.
Brain death is the more traditional route. The diagnosis is clinical: physicians confirm the absence of brainstem reflexes and the inability to breathe independently, typically through a formal apnea test. Spinal reflexes can persist after brain death and sometimes cause limb movements, which can be alarming but do not indicate any remaining brain function.1PubMed Central. Brain death and care of the organ donor Because the heart is still beating in a brain-dead donor, organs continue to receive oxygenated blood right up until surgical recovery, which generally means less damage from oxygen deprivation.
DCD donation is newer in widespread practice and is growing rapidly as a way to expand the donor pool. A Swiss comparison found that DCD donors were more often male, more likely to have had a cardiac arrest before reaching the hospital, and more often died from oxygen deprivation. Organ function before transplant was comparable for kidneys but tended to be poorer for lungs, livers, and the pancreas in DCD cases.2Revista Brasileira de Terapia Intensiva. Organ donation after circulatory death as compared with organ donation after brain death in Switzerland The reason is straightforward: once the heart stops, organs begin losing oxygen immediately. The time between cardiac arrest and the start of cold preservation, called the functional warm ischemia time, was about 29 minutes in that study, and every minute counts.
What Happens Between Death and Recovery
Once a potential donor is identified, a careful evaluation begins. The assessment follows a structured sequence: reviewing the patient’s medical records, interviewing family members about the patient’s health history, performing a physical examination with body measurements, running laboratory and imaging tests, and ultimately conducting a final inventory during the organ recovery surgery itself.3Revista Brasileira de Terapia Intensiva. Guidelines for the assessment and acceptance of potential brain-dead organ donors The goal is to rule out diseases that could be transmitted to recipients and to assess how well each organ is functioning.
Infectious disease screening is one of the trickiest parts. Donors are tested for HIV, hepatitis B, hepatitis C, and other pathogens, but no screening protocol is perfect. The window periods of infections, when someone is recently infected but tests come back negative, remain a challenge.4PubMed Central. Infectious disease transmission during organ and tissue transplantation When a donor’s history raises red flags, such as recent intravenous drug use or other risk factors identified by public health guidelines, the organs are flagged as coming from a donor at increased risk of disease transmission. The transplant center receiving each organ must then obtain specific informed consent from the recipient before proceeding.5American Journal of Transplantation. Donor-Derived Disease Transmission Events in the United States: Data Reviewed by the OPTN/UNOS Disease Transmission Advisory Committee Many recipients accept these organs because the alternative, staying on a waiting list where people die every day, carries its own very real risks.
Keeping Organs Viable in a Dead Body
A brain-dead donor’s body does not manage itself. Without the brainstem directing hormonal signals and cardiovascular reflexes, blood pressure can crash, body temperature drops, and organs begin to deteriorate. The intensive care team essentially takes over every physiological function the brain once coordinated. An easy-to-remember set of clinical targets, sometimes called the “rule of 100,” guides this work: systolic blood pressure above 100 mmHg, urine output above 100 milliliters per hour, blood oxygen levels above 100 mmHg, hemoglobin above a certain threshold, and blood sugar kept in a normal range.6Acute and Critical Care. Medical Management of Brain-Dead Organ Donors
Maintaining blood pressure usually requires vasopressor drugs. Norepinephrine is the first-line choice in most countries, and when higher doses are needed, vasopressin is added as a second agent. Hormone replacement therapy, including thyroid hormone, corticosteroids, and desmopressin, is generally given to all brain-dead donors regardless of whether they appear hemodynamically unstable.7PubMed Central. Hemodynamic management in brain dead donors Body temperature is also actively managed; clinicians aim to keep the core temperature above 35 °C, since hypothermia can trigger cardiac arrhythmias and impair organ function.8PubMed Central. Management of the brain-dead donor in the ICU: general and specific therapy to improve transplantable organ quality
All of this donor management happens while organ procurement organizations coordinate with transplant centers across the country, match organs to recipients, and arrange surgical teams. The window is tight. From the moment brain death is declared, every hour of effective ICU management translates into better-quality organs for the people who receive them.
Organ Preservation After Recovery
Once organs are surgically removed, the clock shifts from managing the donor’s body to preserving the organs outside it. The standard method for decades has been static cold storage: flushing the organ with a cold preservation solution and packing it on ice, typically at around 4 °C. This approach, developed in the late 1960s, remains the default worldwide because it is simple, portable, and effective for many organ types.9PubMed Central. Liver graft preservation methods during cold ischemia phase and normothermic machine perfusion The time between clamping blood flow in the donor and restoring it in the recipient is called the cold ischemia time, and shorter is always better.10PubMed Central. Cold ischemia time in liver transplantation: An overview
A newer approach, normothermic machine perfusion, keeps the organ warm and supplies it with oxygenated blood or a blood-based solution at body temperature. This allows the organ to continue functioning metabolically during transport and, critically, lets surgeons assess the organ’s viability before committing to a transplant.11PubMed Central. Normothermic perfusion: a mini-review A U.S. trial comparing normothermic machine perfusion with cold storage for liver transplants found that the technology was safe and seemed to benefit higher-risk donor livers the most. Livers from DCD donors and those in the highest-risk quartile showed the largest reductions in early graft dysfunction when machine perfusion was used, while lower-risk livers showed less dramatic differences.12Annals of Surgery. Normothermic Machine Perfusion of Donor Livers for Transplantation in the United States The ability to evaluate organs before transplanting them is especially valuable for DCD organs, which have been subjected to that period of warm ischemia and may or may not have sustained too much damage.
How Organs Are Matched to Recipients
Once an organ is available, it enters an allocation system designed to balance medical urgency, expected outcomes, waiting time, and geographic distance. In the United States, different organs use different scoring tools. The liver uses the MELD score, which ranks patients by how sick they are; a higher score means greater urgency and typically moves a patient up the list, even though sicker patients sometimes have worse outcomes after transplant. Kidneys rely on a combination of donor quality indices and estimated post-transplant survival. Lungs use the Lung Allocation Score, and hearts are assigned through a tiered system based on the severity of heart failure.13PubMed Central. Inconsistent values and algorithmic fairness: a review of organ allocation priority systems in the United States
Size matching matters too, especially for hearts. A large-scale study of pediatric heart transplants found that among more than 7,700 donor-recipient pairs, only about a third were well matched by weight. Donor-recipient height mismatch and total cardiac volume turned out to be the best predictors of graft survival, with undersized donors leading to worse outcomes than moderately oversized ones.14PubMed. Assessing Donor-Recipient Size Mismatch in Pediatric Heart Transplantation: Lessons Learned From Over 7,500 Transplants For an adult receiving a kidney, size matching is less critical, but for a child receiving a heart, the geometry of the donor organ relative to the recipient’s chest cavity can be a matter of survival.
Tissue Donation Is Not the Same as Organ Donation
When people think of cadaveric donation, they usually picture hearts and kidneys. But tissues like corneas, skin, bone, heart valves, and tendons are also recovered from deceased donors and transplanted in far greater numbers. In the United Kingdom alone, about 450 multi-tissue donors and 2,500 eye donors contribute to thousands of transplants each year, including over 3,500 corneal transplants annually.15Oxford Academic (BJA: British Journal of Anaesthesia). Tissue and corneal donation and transplantation in the UK
The practical differences are significant. Organs must be recovered within hours of death and transplanted quickly, which is why organ donation requires a controlled hospital setting and an ICU team. Tissues, by contrast, can be recovered up to 24 hours or more after death and can be processed, sterilized, and stored for months or even years before use. A person who dies at home of a heart attack may never be an organ donor, but they could still be a tissue donor. Some solid organ donors also donate tissues during the same recovery procedure, so the distinction between the two categories is partly artificial.
Do DCD and DBD Organs Perform Equally Well?
This is one of the most studied questions in transplant medicine, and the answer is encouraging. For kidneys, a nationwide study found that despite higher rates of early graft loss and delayed graft function in DCD kidneys, ten-year graft and recipient survival were similar between DCD and DBD kidneys.16The Lancet. Outcome of transplantation using kidneys donated after cardiac death: a nationwide study The early stumbles, in other words, did not translate into long-term disadvantage. A study in children found essentially the same thing: no meaningful difference in five-year or ten-year graft survival between DCD and DBD kidney recipients.17PubMed Central. Survival Benefit of Donation After Circulatory Death Kidney Transplantation in Children Compared with Remaining on the Waiting List for a Kidney Donated After Brain Death
Hearts are a different story, and one where the evidence is still maturing. A recent analysis comparing DCD and DBD heart transplants found no significant difference in overall mortality between the two groups after propensity-score matching. First-year survival was virtually identical at about 91.5%. However, differences emerged in years two and three, with DCD recipients showing modestly lower survival at the three-year mark.18JHLT Open. Potential intermediate-term survival differences among heart transplant recipients from circulatory death vs brain death donors DCD heart transplantation is still relatively new, and whether those intermediate-term differences persist as surgical techniques and preservation technology improve is an open question.
Opt-In Versus Opt-Out Consent
Countries handle donation consent in two basic ways. In opt-in systems, a person must actively register their willingness to donate, and family consent is typically sought regardless. In opt-out systems, everyone is presumed to be a willing donor unless they have formally objected. The assumption behind opt-out is that most people support donation but never get around to registering, so flipping the default should increase donor numbers.
The reality is messier. A cross-country panel study found that opt-out countries did have higher deceased donor rates, roughly 14 per million population compared with 10 per million in opt-in countries. But opt-in countries had more living donors, and the total number of kidneys transplanted was only modestly higher in opt-out settings.19PubMed Central. An international comparison of deceased and living organ donation/transplant rates in opt-in and opt-out systems: a panel study A separate policy review argued that when used in isolation, switching from opt-in to opt-out confers little obvious advantage and can even harm broader donation efforts if it leads to public backlash or a false sense that the problem has been solved.20PubMed Central. Assessing Global Organ Donation Policies: Opt-In vs Opt-Out Countries with the highest donation rates tend to combine presumed consent with robust public education, well-funded procurement infrastructure, and trained donor coordinators in hospitals. The consent model alone does not appear to be the decisive factor.
The Dead Donor Rule and Ethical Tensions
Transplant medicine rests on a foundational ethical principle: organ recovery cannot be the cause of death. This is known as the dead donor rule. It sounds simple, but in practice it generates real debate, especially around DCD donation and a technique called normothermic regional perfusion (NRP).
In NRP, after a DCD donor is declared dead and a waiting period has passed, machines restart circulation in the abdominal region (or sometimes the chest as well) to perfuse the organs with warm, oxygenated blood before recovery. This improves organ quality. The ethical concern is that restoring circulation after a person has been declared dead by circulatory criteria could be seen as undoing the very basis of the death declaration.21PubMed Central. The ethics surrounding normothermic regional perfusion in donors following circulatory death The counterargument is that NRP does not restore natural, independent circulation; the flow is artificial, machine-driven, and confined to the organ region. Without the machines, there would be no circulation. The donor remains dead because they permanently lack the ability to sustain circulatory or respiratory function on their own.
A scoping review of the ethical literature found that while the debate is vigorous, most of the transplant community has accepted that death in conventional DCD is determined based on permanence, meaning the loss of circulation will not be reversed under these circumstances, rather than irreversibility, meaning it cannot be reversed under any circumstances.22PubMed Central. Ethical Issues in Normothermic Regional perfusion in Controlled Organ Donation After Determination of Death by Circulatory Criteria: A Scoping Review A small interventional trial using imaging tracers during NRP confirmed that no blood reached the brain, reinforcing the argument that the dead donor rule is not violated.23PubMed. A scintigraphic look at the dead donor rule in donation after the circulatory determination of death with the use of normothermic regional perfusion: A single-center interventional trial But larger studies are still needed, and the ethical conversation continues. These are not purely academic disputes. Public trust in the donation system depends on the perception that the line between life and death is respected.
Religious Perspectives on Cadaveric Donation
Religious belief is one of the most commonly cited reasons people give for hesitating about organ donation, but the official positions of major religions are often more supportive than people assume. A review of the three major monotheistic faiths found that Judaism, Christianity, and Islam all support cadaveric donation, with certain restrictions that vary by tradition.24PubMed. The View of the Three Monotheistic Religions Toward Cadaveric Organ Donation A broader survey of religious umbrella organizations in Germany reached a similar conclusion: deceased donation is widely endorsed as an act of altruism and love, though individual religions place different emphasis on specific aspects of the process, such as how consent is obtained, whether brain death qualifies as true death, and how the deceased body should be treated.25PubMed. Religious and cultural aspects of organ donation: Narrowing the gap through understanding different religious beliefs
The gap between official doctrine and individual belief is often wide. A family may hear from a religious leader that donation is permitted or even encouraged, but still feel that removing organs disrespects the body. These feelings are deeply personal and deserve to be taken seriously by healthcare teams, which is why many organ procurement organizations now include chaplains or cultural liaisons in their approach to donor families.
What Donor Families Experience
Donation happens in the middle of a family’s worst moment. A study of donor family grief found that about 45% of participants reported moderate grief levels and another 45% reported high levels. Among the different dimensions of grief measured, guilt scored the highest on average, while stigmatization scored the lowest.26PubMed Central. Impact of organ donation on grief symptoms in donor families Grief intensity was stronger when the donor was younger and when less time had passed since the donation, which aligns with what you would expect from any traumatic bereavement.
The donation experience itself matters too. Families who felt there were negative aspects about the process reported more symptoms of post-traumatic stress, while those who felt comforted by the act of donating were less likely to experience depression.27PubMed. Exploring the psychological effects of deceased organ donation on the families of the organ donors A qualitative synthesis of family perspectives found that some relatives remained uncertain after consenting, wondering whether they had made the right decision, and some struggled with whether their loved one had truly “died” before organs were recovered.28American Journal of Transplantation. Family Perspectives on Deceased Organ Donation: A Systematic Review and Thematic Synthesis of Qualitative Studies Clear communication from healthcare teams, time to process the situation, and follow-up support after the donation all seem to influence whether families look back on the experience as something that helped them grieve or something that made it harder.
Financial Realities and the Ban on Organ Sales
In most of the world, selling human organs is illegal. The system is built on altruism: donors and their families receive no payment, and organs are allocated based on medical criteria rather than ability to pay. But the infrastructure surrounding donation is not cost-free. Organ procurement organizations, hospitals, transplant surgeons, and preservation technology companies all operate within an economic ecosystem. A financial analysis of organ procurement from deceased donors in the U.S. raised questions about whether the business practices that have developed around altruistic donations are sufficiently transparent, and whether donor families would be entirely comfortable with the commercial environment that has grown from their gifts.29PubMed Central. Financial aspects of organ procurement from deceased donors in the USA-Relevance to xenotransplantation
The tension is real but often unspoken. Tissue banking, in particular, operates in a space where recovered tissues can be processed into commercial products, such as surgical grafts used in orthopedic and dental procedures, that generate substantial revenue. The donor family gave their consent for free; the companies processing and distributing those tissues charge hospitals for the final product. Whether this constitutes a fair arrangement or an exploitation of generosity is a question that the transplant community has not fully resolved, and one that periodically surfaces in investigative journalism and policy debates.